Hikma Pharmaceuticals (HKMPF) Income Statement Analysis - Revenue, Earnings & Profitability Metrics - Stocknear
Stocknear Logo Stocknear
/
Popular
  • KO Coca Cola Company Stock
  • TSLA Tesla Inc Stock
  • AMD Advanced Micro Devices Stock
  • SPY SPDR S&P 500 ETF Trust ETF
  • NVDA Nvidia Stock
    • Start Trial

    Hikma Pharmaceuticals

    PNK: HKMPF · Real-Time Price · USD
    26.93
    0.73 (2.80%)
    At close: May 07, 2025, 12:33 PM

    Hikma Pharmaceuticals Income Statement

    Financials in USD. Fiscal year is January - December.

    undefined peaked at n/a in undefined and hit its lowest at n/a in undefined. Over the past five years, it has declined by undefined%.

    Fiscal Year Q4 2024 Q2 2024 Q4 2023 Q2 2023 Q4 2022 Q2 2022 Q4 2021 Q2 2021
    Period Ending Dec 31, 2024 Jun 30, 2024 Dec 31, 2023 Jun 30, 2023 Dec 31, 2022 Jun 30, 2022 Dec 31, 2021 Jun 30, 2021
    Revenue
    		 1.56B 1.57B 1.45B 1.43B 1.3B 1.21B 1.34B 1.22B
    Cost of Revenue
    		 899M 813M 756M 712M 662M 590M 652M 600M
    Gross Profit
    		 659M 756M 692M 715M 642M 623M 685M 616M
    Operating Income
    		 261M 351M 310M 309M 202M 296M 252M 309M
    Interest Income
    		 n/a 40M 25M 41M 24M 32M 18M 24M
    Pretax Income
    		 167M 288M 79M 202M 18M 215M 225M 319M
    Net Income
    		 133M 226M 59M 131M 15M 173M 173M 248M
    Selling & General & Admin
    		 382M 280M 371M 261M 345M 256M 329M 232M
    Research & Development
    		 77.54M 61M 85M 64M 75M 69M 84M 59M
    Other Expenses
    		 -61.54M 64M n/a n/a n/a n/a n/a n/a
    Operating Expenses
    		 398M 405M 588M 472M 600M 376M 442M 273M
    Interest Expense
    		 n/a n/a n/a n/a n/a n/a n/a n/a
    Selling & Marketing Expenses
    		 n/a n/a n/a n/a n/a n/a n/a n/a
    Cost & Expenses
    		 1.3B 1.22B 1.34B 1.18B 1.26B 966M 1.09B 873M
    Income Tax Expense
    		 34M 59M 18M 71M 1M 41M 53M 71M
    Shares Outstanding (Basic)
    		 221.85M 223.76M 226.45M 222.03M 220.46M 227.93M 233.97M 231.99M
    Shares Outstanding (Diluted)
    		 223.04M 223.76M 222.74M 222.03M 221.82M 228M 234M 232M
    EPS (Basic)
    		 0.60 1.01 0.26 0.59 0.07 0.76 0.74 1.07
    EPS (Diluted)
    		 0.60 1.01 0.26 0.59 0.07 0.76 0.74 1.07
    EBITDA
    		 288M 499M 345M 446M 284M 386M 382M 336M
    EBIT
    		 206M 402M 310M 309M 202M 296M 252M 309M
    Depreciation & Amortization
    		 82M 97M 35M 137M 82M 90M 130M 27M

    Add to Watchlist